about
High hydrostatic pressure treatment of porcine oocytes before handmade cloning improves developmental competence and cryosurvival.Comparison of gene expression and genome-wide DNA methylation profiling between phenotypically normal cloned pigs and conventionally bred controls.Absence of an intron splicing silencer in porcine Smn1 intron 7 confers immunity to the exon skipping mutation in human SMN2.Cloning of a cDNA encoding murine tetranectin.Differences in Hypercholesterolemia and Atherogenesis Induced by Common Androgen Deprivation Therapies in Male Mice.Genetically modified pigs for biomedical research.Large animal models of atherosclerosis--new tools for persistent problems in cardiovascular medicine.Evaluation of porcine stem cell competence for somatic cell nuclear transfer and production of cloned animals.Efficient construction of rAAV-based gene targeting vectors by Golden Gate cloning.Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant.[Epidermolysis bullosa simplex: genotype-phenotype correlation in Danish patients]Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.Site-specific strand bias in gene correction using single-stranded oligonucleotides.Pig gene knockout by rAAV-mediated homologous recombination: comparison of BRCA1 gene knockout efficiency in Yucatan and Göttingen fibroblasts with slightly different target sequences.Functional testing of keratin 14 mutant proteins associated with the three major subtypes of epidermolysis bullosa simplexGeneration and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome[Keratin diseases]High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancerApolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
P50
Q33439845-041A8640-B931-4B1C-823E-F92F6BB843EAQ34055767-C4D3B928-F237-4D33-AC2F-EB74005F62F0Q35180737-F4B1748D-B5AB-4ACB-B7B0-3ACCE3A2B050Q36713821-CEDB68C1-0D57-432E-94CB-C6E29514D7CBQ36714085-B2EB3EDB-6DC6-4075-A303-2F38B97F6BB3Q37997627-D7D5BE6F-6D11-4116-9D60-67A8B16E272AQ38594603-89FB6148-D022-4064-85F0-9A031150E210Q38719311-A3F062BD-EDF9-4C7B-B4D0-43BBF1A45B8AQ42220057-061A6210-A21D-434C-A9CA-CD3AF6B732B1Q44937777-62CE3B40-C4E9-4942-853C-556D0C71B6FAQ50566401-09C443A0-8455-4162-8A0A-3D5F6F078950Q50893120-E4A42B4C-6D8E-4C37-A984-CB10DA186C5BQ51822349-F0CAE198-D83D-4492-94A3-11A9FDFEFD1BQ54745197-79BCFAED-F60B-4765-A19D-D38343977DE3Q61763860-1A7D6971-6B07-457C-B570-F399B4C542ABQ64074438-4A1B315E-382D-460A-8F03-F14228343FFAQ73677942-6D2F05A0-7C7B-4E57-AC79-55784B8B9FE2Q83012505-6969350D-1C4A-4889-A534-EEE5B0A70395Q90652663-5C53E8DA-B323-4936-AD14-E86299CA3495
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charlotte Brandt Sørensen
@ast
Charlotte Brandt Sørensen
@en
Charlotte Brandt Sørensen
@es
Charlotte Brandt Sørensen
@nl
Charlotte Brandt Sørensen
@sl
type
label
Charlotte Brandt Sørensen
@ast
Charlotte Brandt Sørensen
@en
Charlotte Brandt Sørensen
@es
Charlotte Brandt Sørensen
@nl
Charlotte Brandt Sørensen
@sl
prefLabel
Charlotte Brandt Sørensen
@ast
Charlotte Brandt Sørensen
@en
Charlotte Brandt Sørensen
@es
Charlotte Brandt Sørensen
@nl
Charlotte Brandt Sørensen
@sl
P106
P21
P31
P496
0000-0002-4469-8696